Systematic review and meta-analysis of the visual mismatch negativity in schizophrenia

Prune Mazer1,2,3, Fábio Carneiro2,3,4, Juan Domingo5

  • 1ESS, Polytechnic Institute of Porto, Porto, Portugal.

Insights

Visual mismatch negativity (vMMN) is reduced in schizophrenia patients, similar to auditory MMN. This finding suggests vMMN may serve as a biomarker for schizophrenia spectrum disorder and predictive processing deficits.

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Psychiatry

Background:

  • Mismatch negativity (MMN) is an event-related potential reflecting automatic prediction error detection.
  • Reduced auditory MMN is a potential biomarker for schizophrenia, indicating impaired predictive processing.
  • It remains unclear if this deficit extends to the visual domain in schizophrenia spectrum disorder (SSD).

Purpose of the Study:

  • To review and meta-analyze the literature on visual MMN (vMMN) in schizophrenia.
  • To determine if reduced vMMN amplitudes are present in schizophrenia patients.
  • To assess vMMN's potential as a biomarker for SSD.

Main Methods:

  • Systematic literature search for studies on vMMN in schizophrenia.
  • Meta-analysis of eligible studies to calculate a combined effect size.
  • Comparison of vMMN findings with existing auditory MMN research in schizophrenia.

Main Results:

  • Ten eligible studies were included in the meta-analysis.
  • A significant combined effect size (g = -0.63) indicated lower vMMN amplitudes in schizophrenia patients.
  • These results align with findings for auditory MMN in schizophrenia.

Conclusions:

  • Reduced vMMN amplitudes in schizophrenia patients support the hypothesis of widespread predictive processing deficits.
  • vMMN may offer advantages over auditory MMN due to less overlap with attentional processes.
  • vMMN warrants further investigation as a potential biomarker across different stages and groups within SSD.